Bioharvest Sciences (BHST) EBT Margin (2023 - 2026)
Bioharvest Sciences (BHST) posted EBT Margin of -41.45% for the quarter ended Jun 30, 2026, up 6.01 percentage points from -47.46% a year earlier but down 10.95 percentage points from the prior quarter.
Bioharvest Sciences (BHST) EBT Margin (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Bioharvest Sciences was -30.94%, up 8.73 percentage points year-over-year; for the year ended Dec 31, 2025, it was -32.05%, up 19.19 percentage points from the prior year.
- In prior years, Bioharvest Sciences' EBT Margin was -51.23% in the year ended Dec 31, 2024 (+47.91 pp) and -99.15% in the year ended Dec 31, 2023.
- Quarterly EBT Margin has run from a low of -395.86% in the quarter ended Dec 31, 2023 to a high of 103.64% in the quarter ended Jun 30, 2023 over five years.
- On a year-over-year basis, EBT Margin increased in five of the last eight quarters, with an average year-over-year change of +44.14 percentage points.
- The strongest year-over-year quarter for EBT Margin in the past five years was the quarter ended Dec 31, 2024, with a gain of 355.36 percentage points; the weakest was the quarter ended Jun 30, 2024, with a drop of 115.04 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was -30.50% (quarter ended Mar 31, 2026), -25.02% (quarter ended Dec 31, 2025) and -27.02% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Bioharvest Sciences | 26.70 Mn | -43.69 Mn | 5.08 Mn | -41.45% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -41.45% |
| Mar 31, 2026 | -30.50% |
| Dec 31, 2025 | -25.02% |
| Sep 30, 2025 | -27.02% |
| Jun 30, 2025 | -47.46% |
| Mar 31, 2025 | -29.26% |
| Dec 31, 2024 | -40.51% |
| Sep 30, 2024 | -41.12% |
| Jun 30, 2024 | -11.40% |
| Mar 31, 2024 | -123.15% |
| Dec 31, 2023 | -395.86% |
| Sep 30, 2023 | 53.32% |
| Jun 30, 2023 | 103.64% |
Bioharvest Sciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=BHST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "BHST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=BHST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();